Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq®)

Journal of Virological Methods

Volumn 131, Issue 2, 2006, Pages 193-201

  Ranheim, Todd ^a   Mathis, Pamela K ^a   Joelsson, Daniel B ^a   Smith, Mary Ellen ^a   Campbell, Kathryn M ^a   Lucas, Gwendolyn ^a   Barmat, Scott ^a   Melissen, Erin ^a   Benz, Robert ^a   Lewis, John A ^a   Chen, Jie ^a   Schofield, Timothy ^a   Sitrin, Robert D ^a   Hennessey Jr , John P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Potency assay; Quantitative RT PCR; Rotavirus vaccine

Indexed keywords

GENOMIC RNA; LIVE VACCINE; PROTEIN VP7; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; DRUG DETERMINATION; DRUG POTENCY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; VERO CELL; VIRUS CULTURE; VIRUS DETECTION; VIRUS GENOME; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CERCOPITHECUS AETHIOPS; PLAQUE ASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED; VERO CELLS; VIRUS REPLICATION;

ROTAVIRUS;

EID: 30644468981     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.08.013     Document Type: Article

References (17)

1. M. Ciarlet, and M.K. Estes Rotaviruses: basic biology, epidemiology and methodologies G. Bitton Encyclopedia of Environmental Microbiology 2002 John Wiley & Sons New York, USA 2753 2773
2. H.F. Clark, D.I. Bernstein, P.H. Dennehy, P. Offit, M. Pichichero, J. Treanor, R.L. Ward, D.L. Krah, A. Shaw, M.J. Dallas, D. Laura, J.J. Eiden, N. Ivanoff, K.M. Kaplan, and P. Heaton Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants J. Pediatr. 144 2 2004 184 190
3. H.F. Clark, C.J. Burke, D.B. Volkin, P. Offit, R.L. Ward, J.S. Bresee, P. Dennehy, W.M. Gooch, E. Malacaman, D. Matson, E. Walter, B. Watson, D.L. Krah, M.J. Dallas, F. Schodel, M. Kaplan, and P. Heaton Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation Pediatr. Infect. Dis. J. 22 10 2003 914 920
4. H.F. Clark, P.A. Offit, R.W. Ellis, J.J. Eiden, D. Krah, A.R. Shaw, M. Pichichero, J.J. Treanor, F.E. Borian, L.M. Bell, and S.A. Plotkin The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants J. Infect. Dis. 174 Suppl. 1 1996 73 80
5. H.F. Clark, P.A. Offit, R.W. Ellis, D. Krah, A.R. Shaw, J.J. Eiden, M. Pichichero, and J.J. Treanor WC3 reassortant vaccines in children Arch. Virol. (Suppl.) 12 1996 187 198
6. M.K. Estes Rotaviruses and their replication D.M. Knipe P.M. Howley Fields Virology fourth ed. 2001 Lippincott Williams & Wilkins Philadelphia, PA 1747 1785
7. C.R. Gaush, and T.F. Smith Replication and plaque assay of influenza virus in an established line of canine kidney cells Appl. Microbiol. 16 1968 588 594
8. C.A. Heid, J. Stevens, K.J. Livak, and P.M. Williams Real time quantitative PCR Genome Res. 6 1996 986 994
9. G. Kang, M. Iturriza-Gomara, J.G. Wheeler, P. Crystal, B. Monica, S. Ramani, B. Primrose, P.D. Moses, C.I. Gallimore, D.W. Brown, and J. Gray Quantitation of Group A rotaviruses by real-time reverse-transcription- polymerase chain reaction: correlation with clinical severity in children in South India J. Med. Virol. 73 2004 118 122
10. A.Z. Kapikian, Y. Hoshino, and R.M. Chanock Rotaviruses D.M. Knipe P.M. Howley Fields Virology fourth ed. 2001 Lippincott Williams & Wilkins Philadelphia, PA 1787 1833
11. U.D. Parashar, E.G. Hummelman, J.S. Bresee, M.A. Miller, and R.I. Glass Global illness and deaths caused by rotavirus disease in children Emerg. Infect. Dis. 9 2003 565 572
12. J.A.C. Schalk, C. van den Elzen, H. Ovelgonne, C. Baas, and P.M.J.M. Jongen Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR J. Virol. Methods 117 2004 179 187
13. E.M. Smith, M.K. Estes, D.Y. Graham, and C.P. Gerba A plaque assay for the simian rotavirus SA11 J. Gen. Virol. 43 3 1979 513 519
14. D.K. Sood, R.K. Aggarwal, S. Kumar, and J. Sokhey A rapid test for measuring the infectivity of Yellow Fever vaccine Vaccine 13 5 1995 427 428
15. B.A. Schwarz, R. Bange, T.W. Vahlenkamp, R. Johne, and H. Muller Detection and quantitation of group A rotaviruses by competitive and real-time reverse transcription-polymerase chain reaction J. Virol. Methods 105 2002 277 285
16. A.W. Tucker, A.C. Haddix, J.S. Bresee, R.C. Holman, U.D. Parashar, and R.I. Glass Cost-effectiveness analysis of a rotavirus immunization program for the United States JAMA 279 17 1998 1371 1376
17. F. Wang, A. Puddy, W. Mathis, A. Hager, A. Louis, J. McMackin, J. Xu, Y. Zhang, C.Y. Tan, T. Schofield, J. Wolf, and J.A. Lewis Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy Vaccine 23 2005 4500 4508